CCL2 and chronic kidney disease: Our findings suggest that, in the context of CKD, IL-8- and MCP-1-driven mechanisms may be more closely related to localized vascular remodeling/neointimal hyperplasia specific to AV access rather than to the multifactorial processes of atherosclerosis.